AFP and hepatocellular carcinoma: The independent predictor of AFP levels >20 ng/mL was validated by logistic regression to be substantially more common among HCC patients (61.64% vs. 24.36%; p < 0.001) (AOR: 3.09; 95% CI: 1.74-5.48).